搜索临床试验以:HR HER2- breast cancer
总计100116个结果
-
The First Affiliated Hospital with Nanjing Medical...Jiangsu HengRui Medicine Co., Ltd.招聘中
-
First Affiliated Hospital Xi'an Jiaotong University招聘中
-
The First Affiliated Hospital with Nanjing Medical...尚未招聘HER2 阴性乳腺癌
-
King's College LondonGuy's and St Thomas' NHS Foundation Trust; Brighton and Sussex University Hospitals NHS Trust招聘中
-
NSABP Foundation IncGenentech, Inc.; Celcuity, LLC招聘中
-
University of Texas Southwestern Medical CenterMerck Sharp & Dohme LLC; Breast Cancer Research Foundation主动,不招人
-
Fox Chase Cancer CenterGenentech, Inc.主动,不招人
-
Zhejiang Hisun Pharmaceutical Co. Ltd.完全的
-
Fondazione Policlinico Universitario Agostino Gemelli...主动,不招人
-
NSABP Foundation IncEisai Inc.完全的
-
Shandong University未知
-
Zhejiang Cancer Hospital招聘中晚期 HR 阳性和 HER2 阴性乳腺癌; CDK4/6抑制剂治疗失败中国
-
Prof. Wolfgang Janni完全的HER2 阴性和激素受体阳性的转移性乳腺癌 | HER2 阴性循环肿瘤细胞 | 绝经后女性患者德国
-
China Medical University, ChinaShanghai First Song Therapeutics Co., Ltd招聘中
-
Jiangsu HengRui Medicine Co., Ltd.招聘中非鳞状非小细胞肺癌 | HER2 外显子 20 突变大韩民国, 美国, 台湾, 比利时, 西班牙, 中国, 澳大利亚, 火鸡, 意大利, 法国, 德国, 波兰, 俄罗斯联邦
-
Spectrum Pharmaceuticals, Inc终止
-
Nantes University HospitalInstitut National de la Santé Et de la Recherche Médicale, France; Gilead Sciences完全的
-
Alteogen, Inc.Cristália Produtos Químicos Farmacêuticos Ltda.完全的
-
N.N. Petrov National Medical Research Center of...招聘中
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.招聘中